This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Tumor Necrosis Factor Alpha (TNFA), N-His
Product Overview
BioVenic's Recombinant Equine Tumor Necrosis Factor Alpha (TNFA), N-His is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 20.9 kDa. The purity is greater than 95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Tumor necrosis factor is encoded by the TNF gene in horses. Research has shown that serum TNF activity is correlated with clinical criteria of sepsis in equine neonates.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.